Interestingly, Garnier et al. (2022) demonstrated that preincubating EVs isolated from plasma of severe COVID-19 patients with annexin V, and consequently blocking PS exposure, reduces the deleterious EV-mediated effects on endothelial cells [53]. This evidence concerns the gene ANXA5 and COVID-19.